Insurance Issue
9 drugs1,682 FAERS reportsMedDRA PT
GET
/api/v1/reaction/insurance-issueReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Insurance Issue (9)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Garadacimab196.1%
- 2Sebetralstat74.1%
- 3Prucalopride963.8%
- 4Lanadelumab1063.6%
- 5Rifaximin6613.3%
- 6Icatibant2733.2%
- 7Bimekizumab3902.4%
- 8Trientine112.4%
- 9C1 Esterase Inhibitor1192.0%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Hereditary Angioedema5 shared · 0.33
- Pharyngeal Swelling2 shared · 0.20
- Inability To Afford Medication2 shared · 0.14
- Stress5 shared · 0.14
- Therapy Interrupted5 shared · 0.10
- Product Use Issue8 shared · 0.05
- Treatment Noncompliance2 shared · 0.05
- Inappropriate Schedule Of Product Administration5 shared · 0.04
- Intentional Product Use Issue2 shared · 0.04
- Swelling2 shared · 0.04
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.